PFE trade ideas
PFE possible reload op.PFE shows signs of moving too quick to the upside and may retest the breakout level.
PFE Update - Double TopPfizer news thursday; ascending triangle & double top, if it can break over 41.1 PFE can see 41.77, above levels incoming
pfizer stock analysisBased on Technical Analysis the idea is to go long, but just wait that the 40.5USD Resistance level will be broken.
NYSE:PFE
Classic Cup and Handle formation - bullishFundamentals are lining up for this mega cap biotech. Pfizer, an international household for medicine and vaccines will be the biggest distributor of Covid-19 vaccines. Having the precedence of UK emergency approval, there is only upside for this name as they rollout vaccines to the rest of the world. We see every dip as a buy opportunity.
PFE turn around Long opportunitybreakout downward resistance, back to long term uptrend channel on weekly. go long after it stays about $38
PFE continue with new HL and set to surge in priceAs you can see from the dark blue line we keep seeing higher lows and prices set to spike because of news that PFE got approved for emergency covid vaccines.
Remember this is only my opinion and you should always do your own before buying a stock as I cannot guarantee that anything I will say to happen.
+10% PFE : Keep going the market will teach all of us! Made a nice +10% on PFE , I SHARED IT with YOU GUYS if you missed , that's on you .. because you are still learning (and that's fine don't feel a bite on your ego) .
If you'r EGO is inflated = You are screwed in this business .
So keep it small ( size does matter ) I don't want you to blow up your hard earned money because this place isn't friendly.
pfizer inverse Head & Shoulders inverse Head and shoulders pattern on weekly frame and rejected from 200 EMA , great entry point or enter after confirmed breakout .
$PFE Prizer Inc $44.00 Target
PFE stock hitting yearly candle resistance @$41.00 pre market, a break above will
open the potential for a move to $42.00 & $44.00.
Stock is overbought so look after profits
PFIZER D1The UK is the first country in the world to approve a coronavirus vaccine from Pfizer and BioNTech. The vaccine will be available nationwide from December 7th. The authorities have already ordered 40 million doses of the drug. Since for the vaccine to be effective, patients need to be given two injections, the drug will last for 20 million people, The Guardian notes.
The first to receive the vaccine will be Britons with an increased risk of infection - first residents and staff of nursing homes, then other citizens over 80 years old and then healthcare workers. Mass vaccination for people over 50, as well as young citizens with chronic diseases, will become possible with the receipt of more doses of the drug in 2021.
Pfizer and BioNTech also filed applications for their vaccine on November 20 with the US Food and Drug Administration and on November 30 with the European Medicines Agency. If the approval of the American regulator is received, the use of the drug in Europe could begin as early as December. The cost of one dose of the vaccine for EU countries will be 15.5 ($ 18.34) euros, Reuters previously reported.
According to the test results, Pfizer and BioNTech estimated the effectiveness of their vaccine at 95%. Of the 170 volunteers who tested the drug and contracted the coronavirus, 162 received a placebo and only 8 were vaccinated with the candidate vaccine.
